Dermatologic Toxicity Management
Dermatologic Toxicity Management is a specialized domain within cancer drug toxicity management that focuses on the prevention, assessment, and treatment of cutaneous adverse events induced by oncologic therapies.
1.1K
Publications
51.9K
Citations
5.5K
Authors
1.6K
Institutions
Publications per year
2017–2026
243
1.1K
James A. Bonner, Paul M. Harari, J. Giralt et al. · The Lancet Oncology · 2009 · 2K citations
Mario E. Lacouture, Edith P. Mitchell, Bilal Piperdi et al. · Journal of Clinical Oncology · 2010 · 475 citations
Medicine, Oncology, Pharmacology +16
1–5 of 1.1K
5.5K
Memorial Sloan Kettering Cancer Center, United States
32 publications · 2.5K citations
24
h-index
8
h-index
7
h-index
7
h-index
6
h-index
1–5 of 5.5K
1.6K
Memorial Sloan Kettering Cancer Center
New York, United States
23 h-index
134 publications
11.7K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
18 h-index
89 publications
19K citations
Northwestern University
Evanston, United States
15 h-index
38 publications
1.8K citations
University of California, San Francisco
San Francisco, United States
14 h-index
40 publications
3K citations
Heidelberg University
Heidelberg, Germany
14 h-index
48 publications
1.9K citations
Massachusetts General Hospital
Boston, United States
14 h-index
28 publications
2.1K citations
Harvard University
Cambridge, United States
13 h-index
36 publications
2.5K citations

The University of Sydney
Sydney, Australia
12 h-index
36 publications
2.4K citations
1–8 of 1.6K
Repository · 154 publications · 4.7K citations
37
h-index
JAAD · 49 publications · 4.1K citations
36
h-index
44 publications · 3.4K citations
30
h-index
51 publications · 2.3K citations
29
h-index
24 publications · 845 citations
17
h-index
1–5